【摘要】：研究目的1.闡明小細(xì)胞肺癌干細(xì)胞的能量代謝狀態(tài)。2.揭示小細(xì)胞肺癌干細(xì)胞的主要產(chǎn)能途徑。3.探討干預(yù)主要產(chǎn)能途徑對(duì)小細(xì)胞肺癌干細(xì)胞干性的影響。研究方法1.課題組前期工作證明在小細(xì)胞肺癌細(xì)胞系H446中,u PAR+細(xì)胞群富集了干細(xì)胞樣細(xì)胞。因此,本實(shí)驗(yàn)通過(guò)流式細(xì)胞術(shù)從H446中分選出u PAR+細(xì)胞作為腫瘤干細(xì)胞,u PAR-細(xì)胞作為非干癌細(xì)胞。2.比較u PAR+細(xì)胞與u PAR-細(xì)胞的能量代謝狀態(tài):(1)利用Cell Titer-Glo#174;發(fā)光法細(xì)胞活力檢測(cè)試劑盒,檢測(cè)u PAR+細(xì)胞與u PAR-細(xì)胞的ATP含量;(2)檢測(cè)反映u PAR+細(xì)胞與u PAR-細(xì)胞氧化磷酸化水平的相關(guān)指標(biāo):a.利用海馬生物能量測(cè)定儀XF24,檢測(cè)細(xì)胞的氧消耗率和線粒體儲(chǔ)備能力;b.采用活性氧檢測(cè)試劑盒,檢測(cè)細(xì)胞的活性氧水平;c.利用透射電鏡技術(shù),觀察細(xì)胞的線粒體結(jié)構(gòu)。(3)檢測(cè)反映u PAR+細(xì)胞與u PAR-細(xì)胞糖酵解水平的相關(guān)指標(biāo):a.利用海馬生物能量測(cè)定儀XF24,檢測(cè)細(xì)胞的細(xì)胞外酸化率和糖酵解的儲(chǔ)備能力;b.利用熒光標(biāo)記的2-脫氧葡萄糖類似物2-NBDG,檢測(cè)細(xì)胞的葡萄糖攝取能力;c.采用乳酸測(cè)定試劑盒,檢測(cè)細(xì)胞的乳酸生成率。3.比較u PAR+細(xì)胞與u PAR-細(xì)胞的主要產(chǎn)能途徑:(1)單獨(dú)給予糖酵解抑制劑2-DG后,比較u PAR+細(xì)胞與u PAR-細(xì)胞的ATP含量變化。(2)單獨(dú)給予氧化磷酸化抑制劑寡霉素后,比較u PAR+細(xì)胞與u PAR-細(xì)胞的ATP含量變化。(3)聯(lián)合應(yīng)用寡霉素和2-DG后,比較u PAR+細(xì)胞與u PAR-細(xì)胞的ATP含量變化。4.探究寡霉素對(duì)u PAR+細(xì)胞增殖及自我更新能力的影響:(1)通過(guò)MTT實(shí)驗(yàn),比較寡霉素處理前后u PAR+細(xì)胞增殖能力的變化。(2)通過(guò)腫瘤球形成實(shí)驗(yàn),比較寡霉素處理前后u PAR+細(xì)胞體外成球能力的變化。(3)通過(guò)裸鼠移植瘤實(shí)驗(yàn),比較寡霉素處理前后u PAR+細(xì)胞體內(nèi)致瘤能力的影響。結(jié)果1.小細(xì)胞肺癌干細(xì)胞與非干癌細(xì)胞能量代謝狀態(tài)的比較(1)u PAR+細(xì)胞的ATP含量顯著低于u PAR-細(xì)胞(P0.05)。(2)u PAR+細(xì)胞的基礎(chǔ)氧消耗率和線粒體儲(chǔ)備能力均低于u PAR-細(xì)胞(P0.05);進(jìn)一步檢測(cè)兩群細(xì)胞的活性氧水平,結(jié)果顯示u PAR+細(xì)胞的活性氧水平低于u PAR-細(xì)胞;但透射電鏡的結(jié)果表明u PAR+細(xì)胞的線粒體結(jié)構(gòu)與u PAR-細(xì)胞沒(méi)有明顯差異。(3)u PAR+細(xì)胞的細(xì)胞外酸化率和糖酵解儲(chǔ)備能力均低于u PAR-細(xì)胞(P0.05);葡萄糖攝取率檢測(cè)結(jié)果顯示u PAR+細(xì)胞的葡萄糖攝取能力低于u PAR-細(xì)胞(P0.05);而且u PAR+細(xì)胞的乳酸生成率也顯著低于u PAR-細(xì)胞(P0.05)。2.小細(xì)胞肺癌干細(xì)胞與非干癌細(xì)胞主要產(chǎn)能途徑的比較(1)單獨(dú)應(yīng)用寡霉素后,u PAR+細(xì)胞ATP下降幅度大于u PAR-細(xì)胞(P0.05)。(2)單獨(dú)應(yīng)用2-DG后,u PAR-細(xì)胞ATP下降幅度較大(P0.05)。(3)聯(lián)合應(yīng)用2-DG和寡霉素后,u PAR+細(xì)胞的ATP含量高于u PAR-細(xì)胞(P0.05);在缺氧環(huán)境下,聯(lián)合抑制后的u PAR+細(xì)胞ATP水平較常氧環(huán)境更高(P0.05),u PAR-細(xì)胞則無(wú)明顯變化(P0.05)。3.抑制主要產(chǎn)能途徑對(duì)小細(xì)胞肺癌干細(xì)胞增殖和自我更新能力的影響(1)MTT實(shí)驗(yàn)結(jié)果顯示:2-DG能抑制u PAR-細(xì)胞的增殖卻不能抑制u PAR+細(xì)胞的增殖,而寡霉素能夠同時(shí)抑制u PAR-細(xì)胞與u PAR+細(xì)胞的增殖(P0.05);(2)腫瘤球形成實(shí)驗(yàn)結(jié)果顯示:氧化磷酸化的抑制劑寡霉素可顯著影響u PAR+細(xì)胞的成球率和成球體積(P0.05),而2-DG對(duì)其幾乎沒(méi)有影響;(3)動(dòng)物移植瘤實(shí)驗(yàn)結(jié)果顯示:寡霉素處理的u PAR+細(xì)胞致瘤率、致瘤體積和瘤體重量均低于未處理組(P0.05)。結(jié)論1.小細(xì)胞肺癌干細(xì)胞與非干癌細(xì)胞能量代謝狀態(tài)不同,是一群代謝休眠的細(xì)胞。2.小細(xì)胞肺癌干細(xì)胞與非干癌細(xì)胞的產(chǎn)能途徑不同,其主要依賴氧化磷酸化產(chǎn)能。而且,在缺氧條件下還可以通過(guò)線粒體底物水平磷酸化產(chǎn)生部分能量。3.抑制氧化磷酸化可以降低小細(xì)胞肺癌干細(xì)胞的干性。綜上所述,小細(xì)胞肺癌干細(xì)胞是一群能量代謝狀態(tài)相對(duì)不活躍的細(xì)胞,氧化磷酸化是其主要產(chǎn)能途徑,臨床上針對(duì)糖酵解的治療策略只能殺傷非干癌細(xì)胞而對(duì)腫瘤干細(xì)胞無(wú)效。在缺氧條件下,小細(xì)胞肺癌干細(xì)胞可以通過(guò)線粒體底物水平磷酸化產(chǎn)生部分能量;同時(shí),抑制氧化磷酸化可降低小細(xì)胞肺癌干細(xì)胞的干性。因此,該研究將對(duì)研發(fā)靶向癌干細(xì)胞代謝的相關(guān)治療有重要價(jià)值。
[Abstract]:Study objective 1. state of energy metabolism of small cell lung cancer stem cells. To reveal the main productive way of small cell lung cancer stem cells. To investigate the effect of main capacity of intervention on stem cell drying in small cell lung cancer. Study Method 1. The preliminary work of the team demonstrated that in the small cell lung cancer cell line H446, the u PAR + cell population enriched the stem cell-like cells. Therefore, u PAR + cells were selected from H446 as tumor stem cells by flow cytometry, and u PAR-cells were used as non-dry cancer cells. The energy metabolism states of u PAR + cells and u PAR-cells were compared: (1) Cell viability test kit was used to detect the ATP content of u PAR + cells and u PAR-cells. (2) detecting the correlation index of the oxidative phosphorylation level of the u PAR + cell and the u PAR-cell: a. detecting the oxygen consumption rate and the mitochondrial reserve capacity of the cell by using the hippocampal biological energy tester XF24; b, adopting an active oxygen detection kit to detect the active oxygen level of the cell; c. The mitochondrial structure of cells was observed by transmission electron microscope (TEM). (3) detecting the correlation index reflecting the level of the u PAR + cell and the u PAR-cell sugar level: a. detecting the extracellular acidification rate of the cell and the storage capacity of the glycolysis by using the hippocampal biological energy determinator XF24; b. using the fluorescent label 2-deoxyglucose analog 2-NBDG, detecting the glucose uptake capacity of the cells; c. using a lactic acid measurement kit to detect the lactic acid generation rate of the cells. The main productivity approaches of u PAR + cells and u PAR-cells were compared: (1) After administration of glycolytic inhibitor 2-DG alone, the ATP content of u PAR + cells and u PAR-cells were compared. (2) The changes of the ATP content of u PAR + cells and u PAR-cells were compared after the oxidative phosphorylation inhibitor was administered alone. (3) After the combination of oligomycin and 2-DG, the change of ATP content in u PAR + cells and u PAR-cells was compared. The effect of oligomycin on the proliferation and self-renewal of u PAR + cells was studied: (1) The change of uPAR + cell proliferation was compared by MTT assay. (2) By the experiment of tumor ball formation, the change of spherical ability of u PAR + cells before and after treatment with oligomycin was compared. (3) To compare the effect of oligomycin on the tumorigenic ability of u PAR + cells before and after treatment by nude mouse transplantation tumor. Result 1. Compared with the state of energy metabolism of non-dry cancer cells, the ATP content of the small cell lung cancer stem cells and non-dry cancer cells was significantly lower than that of u PAR-cells (P0.05). (2) The basal oxygen consumption rate and mitochondrial reserve capacity of u PAR + cells were lower than that of u PAR-cells (P0.05). However, the results of transmission electron microscope showed that the mitochondrial structure of u PAR + cells was not significantly different than that of u PAR-cells. (3) The extracellular acidification rate and sugar-uptake capacity of u PAR + cells were lower than that of u PAR-cells (P0.05), and the glucose uptake ability of u PAR + cells was lower than that of u PAR-cells (P0.05). Moreover, the lactic acid production rate of u PAR + cells was significantly lower than that of u PAR-cells (P0.05). Compared with the main production capacity of small cell lung cancer stem cells and non-dry cancer cells (1), the decrease of ATP in u PAR + cells was greater than that of u PAR-cells (P0.05). (2) After 2-DG alone, the decrease of u PAR-cell ATP was larger (P0.05). (3) After combined application of 2-DG and oligomycin, the ATP content of u PAR + cells was higher than that of u PAR-cells (P0.05). Inhibition of main production capacity on proliferation and self-renewal of small cell lung cancer stem cells (1) MTT assay showed that 2-DG could inhibit the proliferation of u PAR-cells but could not inhibit the proliferation of u PAR + cells. The results of the experimental results showed that the inhibitor of oxidative phosphorylation could significantly affect the percentage and volume of u PAR + cells (P0.05), but the 2-DG had little effect on it. (3) The experimental results showed that the tumor rate, tumor volume and body weight of the u PAR + cells treated by oligomycin were lower than those in untreated group (P0.05). Conclusion 1. Small cell lung cancer stem cells differ from non-dry cell energy metabolism, a group of dormant cells. The production capacity of small cell lung cancer stem cells and non-dry cancer cells is different, which mainly depends on the oxidative phosphorylation capacity. Moreover, partial energy can also be generated by phosphorylation of the mitochondrial substrate at anoxic conditions. Inhibition of oxidative phosphorylation can reduce the dryness of small cell lung cancer stem cells. To sum up, small cell lung cancer stem cells are a group of cells with relatively inactive energy metabolism state, oxidative phosphorylation is its main production capacity, and the clinical treatment strategy for glycolysis can only kill non-dry cancer cells and is ineffective for tumor stem cells. in anoxic condition, small cell lung cancer stem cells can generate partial energy through horizontal phosphorylation of mitochondrial substrate; meanwhile, inhibition of oxidative phosphorylation can reduce dry of small cell lung cancer stem cells. Therefore, this study will have an important value in the development of related therapies for the metabolism of targeted cancer stem cells.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：R734.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊毅,陸獻(xiàn)瑜,馮本澄,趙美卿,張秀蓮;102例小細(xì)胞惡性腫瘤的免疫組化研究[J];中山醫(yī)科大學(xué)學(xué)報(bào);1989年04期

2 蔡瑞霞,張惠箴,周健華,陳潔晴,卞國(guó)偉;骨小細(xì)胞惡性腫瘤34例病理形態(tài)學(xué)研究[J];臨床與實(shí)驗(yàn)病理學(xué)雜志;2003年01期

3 黃艷;朱克宇;李智;;鼻腔小細(xì)胞鱗癌1例[J];臨床與實(shí)驗(yàn)病理學(xué)雜志;2006年01期

4 趙雪松,王錫明,吳振鐸;鼻腔及副鼻竇小細(xì)胞腫瘤的電子顯微鏡鑒別診斷[J];實(shí)用腫瘤學(xué)雜志;1997年03期

5 陳小紅;韓建德;李揚(yáng);;原發(fā)性皮膚小B細(xì)胞淋巴瘤[J];臨床皮膚科雜志;2007年08期

6 李贊;張真真;張聲;陳余鵬;;鼻腔小細(xì)胞惡性腫瘤26例臨床病理分析[J];臨床與實(shí)驗(yàn)病理學(xué)雜志;2013年02期

7 牛曉敏;廖美琳;;國(guó)際肺癌研究會(huì)推薦的肺癌TNM新分期簡(jiǎn)介[J];腫瘤;2008年03期

8 朱春江;丁暉;勞一平;彭德珍;秦辛玲;李政;趙芹;鄭明慈;;桂林市小細(xì)胞低色素紅細(xì)胞癥人群病因分析[J];實(shí)用兒科臨床雜志;2009年15期

9 張巍巍;劉冠軍;吳冬梅;;61例食管小細(xì)胞惡性腫瘤的病理診斷及分析[J];當(dāng)代醫(yī)學(xué);2013年04期

10 倪恩珍;王亞非;;64層螺旋CT在肺小細(xì)胞神經(jīng)內(nèi)分泌癌的診斷價(jià)值[J];中國(guó)臨床醫(yī)學(xué)影像雜志;2011年07期

相關(guān)會(huì)議論文 前2條

1 劉浩;任浩洋;孫純廣;李然;劉哲元;趙振滿;王睿;;重組人粒細(xì)胞集落刺激因子(rhG-CSF)對(duì)小細(xì)胞肺癌化療后骨髓抑制的有效性和安全性回顧性分析[A];2009年中國(guó)藥學(xué)大會(huì)暨第九屆中國(guó)藥師周論文集[C];2009年

2 劉浩;任浩洋;孫純廣;李然;劉哲元;趙振滿;王睿;;重組人粒細(xì)胞集落刺激因子(rhG-CSF)對(duì)小細(xì)胞肺癌化療后骨髓抑制的有效性和安全性回顧性分析[A];2010年中國(guó)藥學(xué)大會(huì)暨第十屆中國(guó)藥師周論文集[C];2010年

相關(guān)博士學(xué)位論文 前1條

1 文雯;大小細(xì)胞視覺(jué)通路在早期開(kāi)角型青光眼和雙眼競(jìng)爭(zhēng)中作用的功能磁共振成像及視覺(jué)心理物理學(xué)研究[D];復(fù)旦大學(xué);2013年

相關(guān)碩士學(xué)位論文 前3條

1 劉笛;基于生物信息學(xué)的小細(xì)胞食管癌基因表達(dá)譜及拷貝數(shù)變異研究[D];復(fù)旦大學(xué);2014年

2 高翠翠;小細(xì)胞肺癌細(xì)胞系H446腫瘤干細(xì)胞能量代謝的初步研究[D];天津醫(yī)科大學(xué);2015年

3 李慧明;背根節(jié)慢性壓迫模型小細(xì)胞交感敏化的NO-cGMP-PKG信號(hào)通路研究[D];第四軍醫(yī)大學(xué);2012年

，

本文編號(hào)：2301424